Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
11,181,416
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
26,264,313
-
Shares change
-
+19,356
-
Total reported value, excl. options
-
$69,861,906
-
Value change
-
-$1,370,058
-
Number of buys
-
11
-
Number of sells
-
-15
-
Price
-
$2.66
Significant Holders of ImageneBio, Inc. - Common Stock, $0.001 par value (IKNA) as of Q4 2022
41 filings reported holding IKNA - ImageneBio, Inc. - Common Stock, $0.001 par value as of Q4 2022.
ImageneBio, Inc. - Common Stock, $0.001 par value (IKNA) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,264,313 shares
.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (5,018,178 shares), FMR LLC (3,724,575 shares), ORBIMED ADVISORS LLC (2,933,941 shares), BVF INC/IL (2,503,071 shares), Omega Fund Management, LLC (2,249,123 shares), CITADEL ADVISORS LLC (2,155,134 shares), CHI Advisors LLC (1,637,372 shares), Verition Fund Management LLC (1,580,375 shares), Artal Group S.A. (1,549,513 shares), and VANGUARD GROUP INC (979,517 shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.